The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: Evidence from the ProtecT (Prostate testing for cancer and Treatment) study

Cancer Causes and Control

Volumn 21, Issue 11, 2010, Pages 1829-1842

  Rowlands, Mari Anne ^a   Holly, Jeff M P ^a   Gunnell, David ^a   Gilbert, Rebecca ^a   Donovan, Jenny ^a   Lane, J Athene ^a   Marsden, Gemma ^b   Collin, Simon M ^a   Hamdy, Freddie ^b   Neal, David E ^c   Martin, Richard M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adiposity; Insulin like growth factors; Life course

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ADULTHOOD; AGED; ARTICLE; BODY BUILD; BODY MASS; CHILDHOOD; HUMAN; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT GAIN;

ADIPOSITY; ADULT; BODY COMPOSITION; BODY MASS INDEX; COHORT STUDIES; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; OBESITY; PROSTATE; PROSTATIC NEOPLASMS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SOMATOMEDINS; WAIST CIRCUMFERENCE;

EID: 78449280896     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9610-x     Document Type: Article

References (65)

1. DM Parkin F Bray J Ferlay P Pisani 2002 Global Cancer Statistics, 2002 CA Cancer J Clin 55 2 74 108 10.3322/canjclin.55.2.74
2. PD Baade MD Coory JF Aitken 2004 International trends in prostate-cancer mortality: the decrease is continuing and spreading Cancer Causes Control 15 237 241 1:STN:280:DC%2BD2c7ptl2ktQ%3D%3D 10.1023/B:CACO.0000024212.66334.26 15090718
3. World Cancer Research Fund: Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective (2008) 2 edn
4. AG Renehan M Tyson M Egger RF Heller M Zwahlen 2008 Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 9612 569 578 10.1016/S0140-6736(08)60269-X 18280327
5. EE Calle R Kaaks 2004 Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms Nat Rev Cancer 4 8 579 591 1:CAS:528: DC%2BD2cXmtVOhsLk%3D 10.1038/nrc1408 15286738
6. MD Fesinmeyer R Gulati S Zeliadt N Weiss AR Kristal R Etzioni 2009 Effect of population trends in body mass index on prostate cancer incidence and mortality in the United States Cancer Epidemiol Biomarkers Prev 18 3 808 815 10.1158/1055-9965.EPI-08-0784 19258479
7. R MacInnis D English 2006 Body size and composition and prostate cancer risk: systematic review and meta-regression analysis Cancer Causes Control 17 8 989 1003 10.1007/s10552-006-0049-z 16933050
8. ME Wright S-C Chang A Schatzkin, et al. 2007 Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality Cancer 109 675 684 10.1002/cncr.22443 17211863
9. ZH Gong ML Neuhouser PJ Goodman, et al. 2006 Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial Cancer Epidemiol Biomarkers Prev 15 10 1977 1983 10.1158/1055-9965.EPI-06-0477 17035408
10. EE Calle C Rodriguez K Walker-Thurmond MJ Thun 2003 Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults N Engl J Med 348 17 1625 1638 10.1056/NEJMoa021423 12711737
11. SO Andersson A Wolk R Bergstrom, et al. 1997 Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers J Natl Cancer Inst 89 5 385 389 1:STN:280:DyaK2s3hsVGrsw%3D%3D 10.1093/jnci/89.5.385 9060961
12. DA Snowdon RL Phillips WARR Choi 1984 Diet, obesity, and risk of fatal prostate cancer Am J Epidemiol 120 2 244 250 1:STN:280:DyaL2c3nslKlsQ%3D%3D 6465122
13. E Giovannucci EB Rimm MJ Stampfer GA Colditz WC Willett 1997 Height, body weight, and risk of prostate cancer Cancer Epidemiol Biomarkers Prev 6 8 557 563 1:STN:280:DyaK2svgslGiug%3D%3D 9264267
14. JA Efstathiou K Bae WU Shipley, et al. 2007 Obesity and mortality in men with locally advanced prostate cancer Cancer 110 2691 2699 10.1002/cncr.23093 17999404
15. C Rodriguez SJ Freedland A Deka, et al. 2007 Body mass index, weight change, and risk of prostate cancer in the cancer prevention study II nutrition cohort Cancer Epidemiol Biomarkers Prev 16 1 63 69 10.1158/1055-9965.EPI-06-0754 17179486
16. J Ma H Li E Giovannucci, et al. 2008 Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis Lancet Oncol 9 11 1039 1047 1:CAS:528:DC%2BD1cXht12lsbnM 10.1016/S1470-2045(08)70235-3 18835745
17. E Giovannucci D Michaud 2007 The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas Gastroenterology 132 2208 2225 1:CAS:528:DC%2BD2sXmsVyns7Y%3D 10.1053/j.gastro.2007.03.050 17498513
18. A Lukanova S Soderberg P Stattin, et al. 2002 Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden) Cancer Causes Control 13 6 509 516 10.1023/A:1016392129279 12195640
19. RM Martin JMP Holly G Davey Smith D Gunnell 2006 Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65 year follow-up of the Boyd Orr Cohort J Clin Endocrinol Metab 91 3287 3295 1:CAS:528:DC%2BD28Xpslajtr4%3D 10.1210/jc.2006-0745 16787980
20. Y Ben-Shlomo J Holly A McCarthy, et al. 2003 An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood Clin Endocrinol 59 3 366 373 1:CAS:528: DC%2BD3sXnslyhtb8%3D 10.1046/j.1365-2265.2003.01857.x
21. E Kajantie CHD Fall M Seppala, et al. 2003 Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth J Clin Endocrinol Metab 88 3 1059 1065 1:CAS:528:DC%2BD3sXit1egurs%3D 10.1210/jc.2002-021380 12629086
22. SM Gapstur P Kopp BCH Chiu PH Gann LA Colangelo K Liu 2004 Longitudinal associations of age, anthropometric and lifestyle factors with serum total insulin-like growth factor-I and IGF binding protein-3 levels in black and white men: the CARDIA male hormone study Cancer Epidemiol Biomarkers Prev 13 12 2208 2216 1:CAS:528:DC%2BD2cXhtVOjsLnP 15598782
23. S Chang XF Wu H Yu MR Spitz 2002 Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors Cancer Epidemiol Biomarkers Prev 11 8 758 766 1:CAS:528:DC%2BD38XmvVaqsb8%3D 12163330
24. CA Benbassat KC Maki TG Unterman 1997 Circulating levels of insulin-like growth factor (IGF) binding protein-1 and-3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures J Clin Endocrinol Metab 82 5 1484 1491 1:CAS:528:DyaK2sXjtVGmu7o%3D 10.1210/jc.82.5.1484 9141538
25. D Gunnell SE Oliver JL Donovan, et al. 2004 Do height-related variations in insulin-like growth factors underlie the associations of stature with adult chronic disease? J Clin Endocrinol Metab 89 1 213 218 1:CAS:528: DC%2BD2cXmvFCjsg%3D%3D 10.1210/jc.2003-030507 14715852
26. AW Roddam NE Allen P Appleby, et al. 2008 Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies Ann Intern Med 149 7 461 471 18838726
27. M Rowlands D Gunnell R Harris LJ Vatten JMP Holly RM Martin 2009 Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis Int J Cancer 124 10 2416 2429 1:CAS:528:DC%2BD1MXltFaqt7w%3D 10.1002/ijc.24202 19142965
28. SE Oliver D Gunnell J Donovan, et al. 2004 Screen-detected prostate cancer and the insulin-like growth factor axis: results of a population-based case-control study Int J Cancer 108 887 892 1:CAS:528:DC%2BD2cXht1CitLs%3D 10.1002/ijc.11631 14712493
29. HJ Schneider B Saller J Klotsche, et al. 2006 Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects EUR 154 5 699 706 1:CAS:528:DC%2BD28XltV2jsb4%3D
30. NE Allen PN Appleby R Kaaks S Rinaldi GK Davey TJ Key 2003 Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women Cancer Causes Control 14 65 74 10.1023/A:1022518321634 12708727
31. ID Bezemer S Rinaldi L Dossus, et al. 2005 C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC) Cancer Causes Control 16 5 561 572 10.1007/s10552-004-7472-9 15986111
32. IT Gram T Norat S Rinaldi, et al. 2006 Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women Int J Obes 30 11 1623 1631 1:CAS:528:DC%2BD28XhtFekt7nF 10.1038/sj.ijo.0803324
33. Fowke J, Matthews C, Yu H et al. (2009) Racial differences in the association between body mass index (BMI) and serum IGF-1, IGF-2, and IGFBP-3. Endocr Relat Cancer: ERC-09
34. MS Sandhu JM Gibson AH Heald DB Dunger NJ Wareham 2003 Low circulating IGF-II concentrations predict weight gain and obesity in humans Diabetes 52 6 1403 1408 1:CAS:528:DC%2BD3sXmtF2qu7c%3D 10.2337/diabetes.52.6.1403 12765950
35. AW van den Beld WF Blum HA Pols DE Grobbee SW Lamberts 2003 Serum insulin-like growth factor binding protein-2 levels as an indicator of functional ability in elderly men Eur J Endocrinol 148 6 627 634 10.1530/eje.0.1480627 12773134
36. R MacInnis D English 2006 Body size and composition and prostate cancer risk: systematic review and meta-regression analysis Cancer Causes Control 17 8 989 1003 10.1007/s10552-006-0049-z 16933050
37. AR Kristal Z Gong 2007 Obesity and prostate cancer mortality Future Oncol 3 5 557 567 10.2217/14796694.3.5.557 17927521
38. D Albanes SJ Weinstein ME Wright, et al. 2009 Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer J Natl Cancer Inst 101 18 1272 1279 1:CAS:528:DC%2BD1MXhtFyjsrvI 10.1093/jnci/djp260 19700655
39. BY Hernandez SY Park LR Wilkens BE Henderson LN Kolonel 2009 Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohort Cancer Epidemiol Biomarkers Prev 18 9 2413 2421 10.1158/1055-9965.EPI-09-0293 19723920
40. E Kajantie CHD Fall M Seppala, et al. 2003 Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth J Clin Endocrinol Metab 88 3 1059 1065 1:CAS:528:DC%2BD3sXit1egurs%3D 10.1210/jc.2002-021380 12629086
41. L Zuccolo R Harris D Gunnell, et al. 2008 Height and prostate cancer risk: a large nested case-control study (protect) and meta-analysis Cancer Epidemiol Biomarkers Prev 17 9 2325 2336 1:CAS:528:DC%2BD1cXhtVKmtLnI 10.1158/1055-9965.EPI-08-0342 18768501
42. Stunkard AJ, Sorensen T, Schulsinger F (1983) Use of a Danish adoption register for the study of obesity and thinness. The genetics of neurological and psychiatric disorders. Raven Press, New York, pp 115-120
43. CM Bulik TD Wade AC Heath NG Martin AJ Stunkard LJ Eaves 2001 Relating body mass index to figural stimuli: population-based normative data for Caucasians Int J Obes 25 1517 1524 1:STN:280:DC%2BD3Mrms1GhsQ%3D%3D 10.1038/sj.ijo.0801742
44. Expert Panel on Identification EaToOaOiA 1998 Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults Arch Intern Med 158 17 1855 1867 10.1001/archinte.158.17.1855
45. JV Tricoli DL Winter AL Hanlon, et al. 1999 Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer Urology 54 1 178 182 1:STN:280:DyaK1MzktFOitg%3D%3D 10.1016/S0090-4295(99)00129-6 10414748
46. JK Cruickshank AH Heald S Anderson, et al. 2001 Epidemiology of the insulin-like growth factor system in three ethnic groups Am J Epidemiol 154 6 504 513 1:STN:280:DC%2BD3Mrhs1Siuw%3D%3D 10.1093/aje/154.6.504 11549555
47. K Landin-Wilhelmsen L Wilhelmsen G Lappast, et al. 1994 Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin Clin Endocrinol 41 3 351 357 1:CAS:528: DyaK2cXmsVOisrc%3D 10.1111/j.1365-2265.1994.tb02556.x
48. GA Laughlin E Barrett-Connor MH Criqui D Kritz-Silverstein 2004 The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the rancho bernardo study J Clin Endocrinol Metab 89 1 114 120 1:CAS:528:DC%2BD2cXmvFertg%3D%3D 10.1210/jc.2003-030967 14715837
49. K DeLellis S Rinaldi RJ Kaaks LN Kolonel B Henderson ML Le 2004 Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort Cancer Epidemiol Biomarkers Prev 13 9 1444 1451 1:CAS:528:DC%2BD2cXntFCks7c%3D 15342444
50. KG O'Connor JD Tobin SM Harman, et al. 1998 Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men J Gerontol A Biol Sci Med Sci 53A 3 M176 M182
51. JA Langlois CJ Rosen M Visser, et al. 1998 Association between insulin-like growth factor i and bone mineral density in older women and men: the Framingham heart study J Clin Endocrinol Metab 83 12 4257 4262 1:CAS:528:DyaK1cXnvFOrtrc%3D 10.1210/jc.83.12.4257 9851760
52. LA Mucci R Tamimi P Lagiou, et al. 2001 Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? BJU Int 87 9 814 820 1:STN:280:DC%2BD3MzkvFajuw%3D%3D 10.1046/j.1464-410x.2001. 02191.x 11412218
53. NM Probst-Hensch H Wang VHH Goh A Seow H-P Lee MC Yu 2003 Determinants of circulating insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations in a cohort of Singapore men and women Cancer Epidemiol Biomarkers Prev 12 8 739 746 1:CAS:528:DC%2BD3sXmt1elsrY%3D 12917205
54. JV Tricoli DL Winter AL Hanlon, et al. 1999 Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer Urology 54 1 178 182 1:STN:280:DyaK1MzktFOitg%3D%3D 10.1016/S0090-4295(99)00129-6 10414748
55. J Holly C Perks 2006 The role of insulin-like growth factor binding proteins Neuroendocrinology 83 154 160 1:CAS:528:DC%2BD28XhtV2hu7rI 10.1159/000095523 17047378
56. SF Shariat DJ Lamb MW Kattan, et al. 2002 Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and-3 with prostate cancer invasion, progression, and metastasis J Clin Oncol 20 3 833 841 1:CAS:528:DC%2BD38XhsVGmtL0%3D 10.1200/JCO.20.3.833 11821468
57. C Perks EG Vernon AH Rosendahl D Tonge JMP Holly 2007 IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells Oncogene 26 5966 5972 1:CAS:528:DC%2BD2sXps12ntbg%3D 10.1038/sj.onc.1210397 17369847
58. J-P Thissen J-M Ketelslegers LE Underwood 1994 Nutritional regulation of the insulin-like growth factors Endocr Rev 15 1 80 101 1:CAS:528: DyaK2cXkvVWmtrw%3D 8156941
59. H Yu T Rohan 2000 Role of the insulin-like growth factor family in cancer development and progression J Natl Cancer Inst 92 18 1472 1489 1:CAS:528:DC%2BD3cXntFKqsrw%3D 10.1093/jnci/92.18.1472 10995803
60. D Garcia-Galiano MA Sanchez-Garrido I Espejo, et al. 2007 IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients Obes Surg 17 4 493 503 10.1007/s11695-007-9087-1 17608262
61. BA Inman F Harel JF Audet, et al. 2005 Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival Eur Urol 47 5 695 702 10.1016/j.eururo.2004.12.015 15826765
62. R Mehrian-Shai CD Chen T Shi, et al. 2007 Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3 K/Akt pathway activation in glioblastoma and prostate cancer Proc Nat Acad Sci 104 13 5563 5568 1:CAS:528:DC%2BD2sXkt1emtb4%3D 10.1073/pnas.0609139104 17372210
63. L Bubendorf M Kolmer J Kononen, et al. 1999 Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays J Natl Cancer Inst 91 20 1758 1764 1:CAS:528:DyaK1MXntlWmsL4%3D 10.1093/jnci/91.20.1758 10528027
64. DJ Degraff AA Aguiar RA Sikes 2009 Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions Am J Transl Res 1 2 115 130 1:CAS:528:DC%2BD1MXhtFejs7jF 19956425
65. Rose D, O'Reilly K (1998) The ESRC review of government social classifications. Office for national statistics & economic and social research council